Compliance
Compliance System
In accordance with our Compliance Promotion Regulations that establish the fundamentals and procedures of our compliance program, we have appointed a chief compliance officer (our President), compliance supervisor(the general manager of the Legal and Compliance Department), compliance managers(CEO's direct reports), and a compliance secretariat (the Legal and Compliance Department). We are working to maintain a system to continuously strengthen our internal control functions related to compliance and promote compliance measures. The Compliance Promotion Regulations also prescribe the Group’s compliance promotion system, and we are engaged in a variety of activities in cooperation with each company. The Risk, Compliance and Sustainability Committee discusses compliance initiatives, and the chief compliance officer (our President) makes the decisions.
In the event of a suspected compliance violation within the Group, the chief compliance officer (our President) will convene the necessary parties to discuss the outline of the case, the circumstances surrounding it, and the appropriate response. If it is confirmed that a compliance violation has occurred, appropriate measures will be taken and measures to prevent a recurrence will be formulated and implemented promptly. The Risk, Compliance and Sustainability Committee approves the necessary measures to be taken in response to any suspected compliance violations. If the matter is deemed to be of major importance and is likely to have an impact on business operations, it is reported to the Board of Directors.
Item | FYE 03/2022 | FYE 03/2023 | FYE 03/2024 |
---|---|---|---|
No. of compliance violations* | 0 | 0 | 0 |
- *Group total
Compliance Initiatives
Every fiscal year, the compliance supervisor(the general manager of the Legal and Compliance Department) prepares both a plan for promoting compliance and an evaluation report of the plan for the Group. After obtaining approval from the Risk, Compliance and Sustainability Committee, the compliance supervisor also conducts compliance training and other awareness-raising activities.
Whistleblowing System
In order to enable employees to ask questions or express concerns about potential misconduct within the Company, the Group has set up and operates internal and external reporting hotlines in accordance with the Whistleblowing Guidelines.
In addition, if any of the Company’s stakeholders become aware of or suspect any actions by employees of the Alinamin Pharmaceutical Group that violate the laws or regulations, or that could result in a loss of trust from society, they can report these through the Alinamin Pharmaceutical Group Compliance Hotline.*
The Group protects the privacy of employees and other stakeholders who have expressed their concerns in good faith, and ensures that whistleblowers are not disadvantaged in any way as a result of their reports.
*Alinamin Pharmaceutical Group Hotline
Item | FYE 03/2022 | FYE 03/2023 | FYE 03/2024 |
---|---|---|---|
No. of whistleblowing reports made* | 0 | 0 | 2 |
- *Group total
Corruption Prevention Measures
The Alinamin Pharmaceutical Group has established the Anti-Corruption Compliance Regulations to ensure that all aspects of its business are conducted in accordance with the highest standards of legal and ethical conduct.
The Group prohibits any kind of bribery, kickbacks or corrupt practices, directly or through a third party, whether or not they are clearly prohibited by these regulations or by law, and prohibits the provision or offer of things of value (including gifts, meals or entertainment) to anyone for the purpose of improperly obtaining or maintaining business benefits. Similarly, the Group also prohibits soliciting or accepting improper payments with the aim of fraudulently obtaining or maintaining business profits.
The Legal and Compliance Department is in charge of related initiatives for the Group.
Item | FYE 03/2022 | FYE 03/2023 | FYE 03/2024 |
---|---|---|---|
No. of cases of corruption* | 0 | 0 | 0 |
- *Group total